Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and …
IC Barbosa, C Isaia Filho, D Faggion Jr, EC Baracat - Contraception, 2006 - Elsevier
OBJECTIVE: A prospective, open-label, noncomparative, multicenter study was carried out
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a …
J Endrikat, M Cronin, C Gerlinger, A Ruebig, W Schmidt… - Contraception, 2001 - Elsevier
This prospective, open, randomized study was conducted to compare the contraceptive
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …
Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg …
J Endrikat, M Cronin, C Gerlinger, A Ruebig, W Schmidt… - Contraception, 2001 - Elsevier
This prospective, double-blind, randomized study was conducted to compare the
contraceptive reliability, cycle control, and tolerability of a 23-day versus a 21-day oral …
contraceptive reliability, cycle control, and tolerability of a 23-day versus a 21-day oral …
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study
J Endrikat, B Düsterberg, A Ruebig, C Gerlinger… - Contraception, 1999 - Elsevier
This study compares the contraceptive reliability, cycle control, and tolerability of two oral
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …
A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg …
D Serfaty, ML Vree - The European Journal of Contraception & …, 1998 - Taylor & Francis
Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …
[PDF][PDF] Cycle control, safety and acceptability of a new oral contraceptive containing ethinylestradiol 15 micrograms and gestodene 60 micrograms
L Jaithitivit, U Jaisamrarn… - Journal of the Medical …, 2012 - thaiscience.info
Objective: To determine cycle control, safety, and acceptability of a 24-day oral contraceptive
regimencontaining 15 micrograms of ethinylestradiol and 60 micrograms of gestodene …
regimencontaining 15 micrograms of ethinylestradiol and 60 micrograms of gestodene …
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …
S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
A clinical overview of a new triphasic contraceptive containing gestodene.
T Christie - International Journal of Fertility, 1989 - europepmc.org
In three ongoing open studies conducted by 50 investigators in Europe, South America, and
New Zealand, 639 subjects followed a new triphasic regimen of gestodene (GTD) and …
New Zealand, 639 subjects followed a new triphasic regimen of gestodene (GTD) and …
Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg
Gestodene Study Group 324 - The European Journal of …, 1999 - Taylor & Francis
Objectives: This multicenter, open-label study was conducted to compare the cycle control,
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 μg ethinylestradio1/75 μg …
S Taneepanichskul, R Kriengsinyot, U Jaisamrarn - Contraception, 2002 - Elsevier
The purpose of this study was to compare cycle control, efficacy and side effects of an oral
contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a reference …
contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a reference …